Jacob Hughes
Stock Analyst at Wells Fargo
(1.39)
# 2,609
Out of 4,479 analysts
14
Total ratings
50%
Success rate
7.27%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $37.58 | +17.08% | 3 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $25.99 | +107.77% | 1 | Sep 6, 2022 | |
| RVNC Revance Therapeutics | Maintains: Equal-Weight | $17 → $24 | $2.42 | +891.74% | 2 | Aug 25, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $6.22 | +109.00% | 2 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $15.56 | +259.90% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $7.49 | +407.34% | 2 | May 4, 2022 | |
| TEVA Teva Pharmaceutical | Maintains: Equal-Weight | n/a | $16.55 | - | 2 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | n/a | $7.11 | - | 1 | Mar 23, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $37.58
Upside: +17.08%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $25.99
Upside: +107.77%
Revance Therapeutics
Aug 25, 2022
Maintains: Equal-Weight
Price Target: $17 → $24
Current: $2.42
Upside: +891.74%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $6.22
Upside: +109.00%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $15.56
Upside: +259.90%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $7.49
Upside: +407.34%
Teva Pharmaceutical
Jul 29, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $16.55
Upside: -
Bausch Health Companies
Mar 23, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $7.11
Upside: -